The present invention provides a method for determining sensitivity of the tumor cells to an EGFR and/or HER
2
inhibitor by evaluating inhibitory capacity of an Src inhibitor in a sample for measuring tyrosine kinase activity which is prepared from a biological sample containing tumor cells, a computer program and a method for determining effectiveness.
本发明提供了一种方法,通过评估样本中Src
抑制剂的抑制能力,测量来自含有肿瘤细胞的
生物样本的
酪氨酸激酶活性,以确定肿瘤细胞对
EGFR和/或HER2
抑制剂的敏感性,以及一种用于确定有效性的计算机程序和方法。